New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent ...

With one in eight adults taking drugs like Ozempic and Mounjaro, emerging evidence shows that the medication has potential to ...

U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss ...

Novo Nordisk goes "on the offensive" following Trump deal that also included rival Eli Lilly, putting an exclamation point on ...

That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, ...

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

If you've been denied access to a GLP-1 medication for weight loss, you are not alone. However, there are new science-backed options you should know about that don't require a prescription. Health ...

Approximately one in eight Americans has taken a GLP-1 or glucagon-like peptide-1 receptor agonist. These medications were originally developed to help manage type 2 diabetes, but they also support ...

ABC News' Dr. Tara Narula breaks down new research on how GLP-1 medications, commonly used for weight loss and diabetes, may also benefit heart health. Senate Republicans defy Vance's warning, vote to ...

If your patients are taking GLP-1s, you’ve explained the common side effects, such as gastrointestinal (GI) issues and muscle-loss implications. However, GLP-1 receptor agonists, often prescribed for ...